0001209191-21-020592.txt : 20210315
0001209191-21-020592.hdr.sgml : 20210315
20210315193818
ACCESSION NUMBER: 0001209191-21-020592
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210312
FILED AS OF DATE: 20210315
DATE AS OF CHANGE: 20210315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ryali Sriram
CENTRAL INDEX KEY: 0001762893
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 21743132
MAIL ADDRESS:
STREET 1: C/O EIGER BIOPHARMACEUTICALS, INC.
STREET 2: 2155 PARK BLVD.
CITY: PALO ALTO
STATE: CA
ZIP: 94306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-12
0
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001762893
Ryali Sriram
C/O EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BLVD.
PALO ALTO
CA
94306
0
1
0
0
Chief Financial Officer
Common Stock
2021-03-12
4
A
0
16250
0.00
A
18152
D
Stock Option (Right to Buy)
9.99
2021-03-12
4
A
0
97500
0.00
A
2031-03-11
Common Stock
97500
97500
D
Represents shares underlying Restricted Stock Units award that will vest in three equal annual installments measured from March 12, 2021.
Includes 274 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on March 5, 2021.
The option vests in equal monthly installments over 48 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date.
/s/ Sriram Ryali
2021-03-15